IPP Bureau
Five manufacturers get license to produce Black Fungus drug
By IPP Bureau - May 23, 2021
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
Orchid Pharma Q4FY21 consolidated loss at Rs. 24.72 Cr
By IPP Bureau - May 23, 2021
The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021
Bharat Parenterals receives license for Favipiravir Oral Suspension
By IPP Bureau - May 23, 2021
The product patent has been already filed under fast track approval
Orchid Pharma develops new molecule OCID-5090
By IPP Bureau - May 23, 2021
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
Balaxi records Q4 FY21 revenue of Rs. 53 Cr
By IPP Bureau - May 22, 2021
Drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday
Govt. monitoring supply of COVID-19 essential drugs
By IPP Bureau - May 21, 2021
Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.
Cipla launches Covid-19 RT-PCR test Viragen
By IPP Bureau - May 21, 2021
This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19
India's first indigenous COVID-19 RT-PCR testing kit approved
By IPP Bureau - May 21, 2021
This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips
Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency
By IPP Bureau - May 21, 2021
Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.
Remdesivir production increased to 119 lakh vials per month
By IPP Bureau - May 18, 2021
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
Sun Pharma Advanced Research Q4FY21 loss at Rs. 56.72 Cr
By IPP Bureau - May 18, 2021
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
NATCO signs licensing agreement with Lilly for Baricitinib
By IPP Bureau - May 18, 2021
Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
Shilpa Medicare to produce 50 mn doses of Sputnik V Vaccine
By IPP Bureau - May 18, 2021
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
Outlook promising for Cipla: HDFC Securities
By IPP Bureau - May 18, 2021
The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.
Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities
By IPP Bureau - May 18, 2021
Dr. Reddy's has the rights to distribute 250mn doses in India
